7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Medical Condition

Aplastic Anemia

HematologyICD-10: D61.9
Aplastic Anemia
Condition at a Glance
ICD-10 codeD61.9
SpecialtyHematology
Treatment options1 option at Acibadem
Specialists18 doctors available

Quick answer

Aplastic anemia is a rare blood disorder in which the bone marrow does not make enough red blood cells, white blood cells, and platelets, causing fatigue, infections, and bleeding problems. Treatment depends on the cause and severity and may include supportive care, medicines to stimulate blood production or suppress immune attack, and in suitable cases a stem cell transplant, with…

What is aplastic anemia?

Aplastic anemia is a rare and serious blood disorder in which the bone marrow — the soft, spongy tissue inside your bones that produces blood cells — stops making enough new blood cells. The word “aplastic” means the marrow has become empty or underactive, and “anemia” refers to a shortage of red blood cells. Despite its name, the condition affects more than red blood cells. In aplastic anemia, the bone marrow fails to produce enough of all three main types of blood cells: red blood cells, which carry oxygen; white blood cells, which fight infection; and platelets, which help blood clot and stop bleeding.

To understand what is aplastic anemia in simple terms, it helps to picture the bone marrow as a factory. Inside this factory are stem cells — immature cells that grow into all the different blood cells your body needs. In aplastic anemia, these stem cells are damaged or destroyed, so the factory slows down or nearly stops. When doctors see low counts of all three blood cell types together, they call this pancytopenia.

Aplastic anemia can affect people of any age, but it is diagnosed most often in two groups: young adults, typically in their late teens and twenties, and adults over about 60 years of age. It affects men and women in roughly equal numbers. The condition can develop slowly over weeks or months, or it can appear suddenly. Severity ranges from mild forms that need only monitoring to severe forms that can be life-threatening without treatment. Aplastic anemia is not a cancer, although some of its symptoms and treatments overlap with those used for blood cancers, and it is usually managed by hematologists — doctors who specialize in blood disorders.

Symptoms of aplastic anemia

Aplastic anemia symptoms are caused by the shortage of each type of blood cell, so they often appear in combinations. Some people notice symptoms gradually, while others become unwell quite quickly. Common symptoms include:

  • Fatigue and weakness — feeling unusually tired even after rest, caused by low red blood cells
  • Shortness of breath — especially with activity such as climbing stairs
  • Pale skin — a noticeably lighter skin tone, or paleness inside the lips and eyelids
  • Dizziness or lightheadedness — sometimes with headaches
  • Rapid or irregular heartbeat — the heart works harder to move oxygen with fewer red blood cells
  • Frequent or prolonged infections — fevers, sore throats, or infections that keep coming back, caused by low white blood cells
  • Easy bruising — bruises that appear without a clear injury, caused by low platelets
  • Bleeding that is hard to stop — nosebleeds, bleeding gums, heavy menstrual periods, or blood in urine or stool
  • Petechiae — tiny, flat, pinpoint red or purple spots on the skin caused by small bleeds under the surface

How symptoms present often depends on how severe the condition is and how quickly it develops. In mild or moderate aplastic anemia, a person may feel only tired and slightly run-down, and the problem is sometimes discovered by chance on a routine blood test. In severe aplastic anemia, symptoms tend to be more dramatic: high fevers from infections, significant bleeding, and profound exhaustion. When the condition develops gradually, the body may partly adjust to lower blood counts, so a person can have surprisingly low counts before feeling seriously ill.

It is worth noting that none of these symptoms is unique to aplastic anemia. Fatigue, bruising, and infections have many possible causes, most of them far more common than aplastic anemia. Only blood tests and marrow examination can determine the true cause.

Causes and risk factors

In most cases, aplastic anemia is thought to be an autoimmune condition — meaning the body’s own immune system mistakenly attacks and destroys the stem cells in the bone marrow. Why the immune system does this is often unclear. When no specific trigger can be identified, doctors call the condition idiopathic aplastic anemia, and this accounts for the majority of cases.

Known or suspected aplastic anemia causes and risk factors include:

  • Exposure to toxic chemicals — such as benzene (found in some industrial settings), certain pesticides, and other solvents
  • Certain medications — some antibiotics, anti-seizure drugs, and other medicines have rarely been linked to marrow failure
  • Cancer treatment — chemotherapy and radiation therapy intentionally slow the bone marrow; in most people the marrow recovers, but in rare cases lasting damage occurs
  • Viral infections — some viruses, including hepatitis viruses, Epstein-Barr virus, cytomegalovirus, HIV, and parvovirus, have been associated with aplastic anemia
  • Autoimmune diseases — conditions in which the immune system attacks healthy tissue can occasionally involve the bone marrow
  • Pregnancy — rarely, aplastic anemia develops during pregnancy and sometimes improves after delivery
  • Inherited conditions — some people are born with genetic disorders, such as Fanconi anemia, that cause bone marrow failure, usually appearing in childhood or young adulthood

It is important to understand that aplastic anemia is not contagious — you cannot catch it from another person. It is also not caused by diet, and in most cases it is not inherited. Many people diagnosed with aplastic anemia have no identifiable risk factor at all, and having a risk factor does not mean a person will develop the disease.

Aplastic anemia is related to, but distinct from, other bone marrow conditions. Your doctor may also test for a condition called paroxysmal nocturnal hemoglobinuria (PNH), a rare disorder in which red blood cells break down too easily, because the two conditions sometimes occur together.

Diagnosis

An aplastic anemia diagnosis is made through a combination of blood tests, a bone marrow examination, and tests to rule out other conditions that can look similar. Because low blood counts have many possible causes, doctors follow a careful step-by-step process.

Blood tests

The first step is usually a complete blood count (CBC), a common laboratory test that measures the levels of red blood cells, white blood cells, and platelets. In aplastic anemia, all three counts are typically low. Doctors also often order a reticulocyte count, which measures young red blood cells recently released by the marrow. A very low reticulocyte count suggests the marrow is not producing new cells as it should. Additional blood tests may check vitamin levels, liver and kidney function, and look for evidence of viral infections or autoimmune disease.

Bone marrow aspiration and biopsy

The key test for confirming aplastic anemia is a bone marrow biopsy. In this procedure, a doctor uses a needle — usually inserted into the back of the hip bone under local anesthesia — to remove a small sample of liquid marrow (aspiration) and a small core of marrow tissue (biopsy). Under the microscope, the marrow in aplastic anemia appears “hypocellular,” meaning it contains far fewer blood-forming cells than normal and is largely replaced by fat. Importantly, the biopsy also allows doctors to rule out other causes of low counts, such as leukemia (blood cancer), myelodysplastic syndromes (conditions in which marrow cells are abnormal), or marrow infiltration by other diseases.

Additional tests

Depending on the situation, doctors may also order genetic and chromosome tests, particularly in children and young adults, to check for inherited bone marrow failure syndromes; specialized blood tests for PNH; and imaging or other studies if another underlying condition is suspected. If a bone marrow transplant is being considered, tissue-typing tests (called HLA typing) are performed for the patient and potential family donors.

Severity grading

Once confirmed, aplastic anemia is graded as moderate, severe, or very severe, based on how low the blood counts are and how empty the marrow appears. This grading matters because it strongly influences which treatment is recommended and how urgently treatment should begin.

Treatment options

Aplastic anemia treatment depends on the severity of the disease, the patient’s age and overall health, and whether a suitable stem cell donor is available. Care is typically coordinated by a specialized hematology department, where blood disorders are diagnosed and managed. A general overview of care pathways for this condition is also available on the aplastic anemia treatment page.

Observation and supportive care

For mild or moderate aplastic anemia without troubling symptoms, doctors may recommend careful monitoring with regular blood tests rather than immediate treatment, since counts sometimes remain stable for long periods. Supportive care is also central at every stage of the disease. This may include blood transfusions — red blood cell transfusions to relieve anemia symptoms and platelet transfusions to prevent or control bleeding. Transfusions ease symptoms but do not fix the underlying marrow problem, and repeated transfusions are managed carefully to limit complications such as iron buildup. Antibiotics, antiviral medicines, and antifungal medicines are used promptly to treat or prevent infections, because infection is one of the most serious risks when white blood cell counts are very low.

Immunosuppressive therapy

Because most aplastic anemia is driven by an immune attack on the bone marrow, medicines that calm the immune system are a mainstay of treatment, especially for patients who are older or who do not have a matched stem cell donor. The standard combination usually includes antithymocyte globulin (ATG), a medicine given by infusion that reduces the immune cells attacking the marrow, together with cyclosporine, an oral medicine that continues to suppress the immune response. In many cases, blood counts improve over several months, although responses vary, improvement can be partial, and relapse is possible. Some patients also receive eltrombopag, a medicine that stimulates the bone marrow to produce blood cells, which may be added to improve the chance of a response.

Bone marrow (stem cell) transplantation

A bone marrow transplant — also called a hematopoietic stem cell transplant — replaces the failed marrow with healthy stem cells from a donor. It is generally the preferred treatment for younger patients with severe aplastic anemia who have a matched sibling donor, because it offers the possibility of a long-term cure. Before the transplant, the patient receives chemotherapy, sometimes with other conditioning treatment, to prepare the body to accept the donor cells. Transplantation carries significant risks, including infection and graft-versus-host disease, a condition in which the donated immune cells attack the recipient’s body, so the decision involves weighing benefits and risks for each individual. When no matched sibling is available, transplants from matched unrelated donors or partially matched family donors may be considered in selected patients.

Other measures

If a specific cause is identified — for example a medication or chemical exposure — removing that trigger is an essential part of treatment. In the rare cases linked to pregnancy, counts sometimes improve after delivery, though close specialist monitoring is needed. Surgery has no direct role in treating aplastic anemia itself, apart from procedures related to transplantation and supportive care, such as placing a central venous catheter (a soft tube in a large vein) for infusions and transfusions.

Living with aplastic anemia and outlook

The outlook for aplastic anemia has improved considerably over recent decades thanks to advances in transplantation, immunosuppressive therapy, and supportive care. Many patients — particularly younger people who undergo a successful bone marrow transplant — can achieve long-term remission or cure. Others respond well to immunosuppressive treatment and live full lives, though some need ongoing medication or experience relapses that require further treatment. Outcomes depend on many factors, including disease severity, age, overall health, response to treatment, and donor availability, so no doctor can promise a specific result for an individual patient.

Day to day, people living with aplastic anemia are usually advised to take practical precautions while their blood counts are low. These often include avoiding crowds and people with contagious illnesses when white cell counts are low; practicing careful hand hygiene; avoiding contact sports and activities with a high risk of injury when platelets are low; using a soft toothbrush and an electric razor to reduce bleeding risk; and avoiding medicines such as aspirin or ibuprofen that can affect clotting, unless a doctor approves them. Regular follow-up blood tests are important, even when a person feels well, because they allow the care team to detect changes early.

Living with a rare, serious illness can also be emotionally demanding. Fatigue, uncertainty about the future, and long treatment courses affect mood and daily life. Many patients find it helpful to involve family in medical discussions, ask their care team to explain results in plain language, and seek psychological support or patient support groups when needed. Long-term follow-up is generally recommended even after successful treatment, because a small proportion of patients can later develop related bone marrow conditions, and early detection matters. Within some hospital systems, including Acibadem, long-term follow-up for this condition is provided through the hematology specialty.

Frequently asked questions

What is aplastic anemia in simple terms?

Aplastic anemia is a condition in which the bone marrow — the tissue inside bones that makes blood — stops producing enough red blood cells, white blood cells, and platelets. In most cases this happens because the immune system mistakenly attacks the marrow’s stem cells. The result is fatigue, a higher risk of infection, and easy bleeding or bruising. It is rare, it is not a cancer, and it is not contagious.

How serious is aplastic anemia?

Severity varies widely. Mild or moderate cases may need only monitoring, while severe aplastic anemia is a life-threatening condition that requires prompt specialist treatment, mainly because of the risks of serious infection and bleeding. With modern treatments such as bone marrow transplantation and immunosuppressive therapy, many patients do well, but outcomes depend on individual factors, so it is important to discuss your specific situation with a hematologist.

Can aplastic anemia be cured?

In many cases, yes — particularly with a successful bone marrow transplant, which can restore normal blood production and is often considered curative, especially in younger patients with a matched donor. Immunosuppressive therapy also leads to lasting improvement for many patients, although some experience only a partial response or later relapse. No treatment can be guaranteed to work for every person, and long-term follow-up is generally recommended even after a good response.

What are the first symptoms of aplastic anemia?

Early aplastic anemia symptoms are often vague: unusual tiredness, paleness, shortness of breath with activity, or getting infections more easily. Some people first notice easy bruising, bleeding gums, frequent nosebleeds, or tiny red spots on the skin called petechiae. Because these symptoms have many common causes, they do not mean a person has aplastic anemia — but persistent or unexplained symptoms should be checked with a blood test.

What causes aplastic anemia?

In most people, no specific cause is found, and the condition is believed to result from the immune system attacking the bone marrow. Known aplastic anemia causes and triggers include exposure to certain chemicals such as benzene, some medications, radiation or chemotherapy, certain viral infections, and rare inherited bone marrow failure syndromes. Diet and lifestyle are not considered causes, and in most cases the condition is not passed from parent to child.

How is aplastic anemia diagnosed?

Diagnosis starts with a complete blood count, which typically shows low levels of red cells, white cells, and platelets. The condition is confirmed with a bone marrow aspiration and biopsy, in which a small sample of marrow is taken from the hip bone and examined under a microscope. Doctors also run additional blood, viral, and sometimes genetic tests to rule out other conditions, such as leukemia or inherited marrow disorders, that can cause similar findings.

How long does recovery from aplastic anemia take?

Recovery timelines vary considerably. After immunosuppressive therapy, blood counts often improve gradually over three to six months or longer, and some patients need continued medication for an extended period. After a bone marrow transplant, the initial hospital phase is followed by months of recovery and close monitoring while the new marrow establishes itself and the immune system rebuilds. Your care team can give you a more realistic timeline based on your treatment and response.

When to see a doctor

If you have persistent, unexplained fatigue, frequent infections, or unusual bruising or bleeding, arrange to see a doctor and ask whether a blood test is appropriate. If you have already been diagnosed with aplastic anemia, your care team will tell you which symptoms need urgent attention — because low white cells and platelets can turn minor problems into emergencies quickly.

Seek urgent medical care right away if you experience any of the following red-flag warning signs:

  • Fever — especially a temperature of about 38°C (100.4°F) or higher, chills, or shaking; in a person with low white cells, fever is a medical emergency
  • Bleeding that will not stop — including nosebleeds lasting more than a few minutes, bleeding gums, or blood in urine, stool, or vomit
  • A sudden severe headache, confusion, or vision changes — which could signal bleeding inside the head
  • Widespread new bruising or a rapid spread of petechiae — tiny red or purple pinpoint spots on the skin
  • Severe shortness of breath, chest pain, or a racing heartbeat — possible signs of severe anemia straining the heart
  • Extreme weakness, fainting, or inability to stay awake
  • Signs of serious infection — such as a spreading skin redness, severe sore throat, productive cough, or pain when urinating, especially with fever

Do not wait to see whether these symptoms improve on their own. In someone with very low blood counts, early treatment of infection and bleeding can be lifesaving, and hospital teams would rather assess a false alarm than miss a true emergency.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page

Medically reviewed by the Acıbadem International Medical Board — September 2, 2026
See our medical review board →

Published: June 14, 2026Last updated: September 2, 2026
Update history
  • PublishedJune 14, 2026
  • Medical review approvedSeptember 2, 2026
  • Last content updateSeptember 2, 2026
Treatments

Treatments for This Condition

Departments

Care at Acibadem

Specialists

Doctors Who Treat This Condition

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.